This recording of the AAOS/FDA Townhall, held at the AAOS 2023 Annual Meeting, contains valuable content for orthopaedic surgeons and industry professionals to learn about the latest developments in the field of orthopaedics. Presentations emphasize the need for collaboration, innovation, and reliable data to improve patient outcomes and shape the future of the field.

Presentations

AAOS Commitment to Quality & Innovation (Strategic Plan Introduction)

Felix H. Savoie III, MD, FAAOS, AAOS President

The AAOS Revolution in Value-Based and Quality Care

David Jevsevar, MD, MBA, FAAOS, Chair of Research and Quality Council, AAOS

The AAOS Registries Drive Quality and Innovation

William J. Maloney, MD, FAAOS, President, Chair of AAOS Registries Oversight Committee (ROC), Former AAOS

An Introduction to the American Spine Registry

Steven D. Glassman, MD, FAAOS, ASR Executive Committee AAOS Chair, AAOS Registry Oversight Committee (ROC) Member

Registries and NEST for Product Quality

Jeffrey Shuren, MD, JD, Director, Center for Devices and Radiologic Health (CDRH), FDA

Quality Over the Total Product Lifecycle

CAPT Raquel Peat, PhD, MPH, Director, OHT6: Office of Orthopedic Devices, Office of Product Evaluation and Quality, CDRH, FDA

Industry’s Commitment to Innovation

Kevin Lobo, CEO of Stryker, Nominated by OSMA

Shaping the Future of Innovation: Surgeon and Industry Collaboration to Advance Meaningful Solutions for Patients

Aldo Denti, Chairperson of DePuy, Nominated by OSMA

Future Opportunities in Innovation/Panel Discussion

Moderated by S. Raymond Golish MD, PhD, MBA, FAAOS, Member Devices Biologics & Technology Committee, AAOS